CVS Health Corp., US1266501006

CVS Health stock sets November 4 earnings date

Published on 10/06/2026 at 13:10 | Editorial responsibility: Rafael Müller, Editor-in-Chief AD HOC NEWS

CVS Health stock posted adjusted EPS of USD 2.58 in Q2 2026, above USD 1.87 consensus. CVS Health set November 4 for its next results.

Isometrische 3D-Illustration der Gesundheitsversorgungskette von Produktion über Apotheke bis Patient
CVS Health Corp. isometrisches 3D-Diagramm der Wertschöpfungskette von Pharma bis Patient, ISIN US1266501006, Illustration mit AI erstellt.

CVS Health Corp. (ISIN US1266501006) was last at USD 87.01 on the NYSE on October 5, 2026 at 4:00 p.m. ET, up 0.64 percent on the session. The company has set November 4, 2026, for its third-quarter results, giving the stock a clear near-term reporting date, as Yahoo Finance reported on October 5, 2026.

November 4 is the next test

The upcoming report follows a strong second quarter. According to MarketBeat on October 6, 2026, CVS Health reported adjusted EPS of USD 2.58 against USD 1.87 consensus for the quarter released on August 5, 2026. Revenue reached USD 106.10 billion, an increase of 7.3 percent from the prior-year quarter.

That earnings comparison matters because the company also set fiscal-year 2026 adjusted EPS guidance at USD 7.90-8.10, while analysts cited by MarketBeat placed the current-year estimate at USD 8.02. The November report will show whether the second-quarter improvement is carrying into the second half.

Targets sit above the share price

MarketBeat's October 6, 2026 consensus was Moderate Buy from 23 analysts, including 22 Buy ratings and one Hold rating, with an average twelve-month price target of USD 107.24. That target lies 23.3 percent above the NYSE price of USD 87.01, a quantified gap that leaves the November earnings figures central to the valuation debate.

The latest quote places CVS Health below its 50-day moving average of USD 94.27 and its 200-day moving average of USD 92.09, while the 52-week range runs from USD 69.51 to USD 110.68. The stock is therefore 21.4 percent below its yearly high, but 25.2 percent above its yearly low.

Dividend date adds a second checkpoint

Shareholders also have an October 22, 2026 ex-dividend date and a November 2, 2026 payment date for the USD 0.665 quarterly dividend, according to MarketBeat. The annualized dividend is USD 2.66, which the same report lists at a 3.1 percent yield.

CVS Health stock stays below its yearly high

CVS Health stock was last at USD 87.01 on the NYSE on October 5, 2026 at 4:00 p.m. ET, with a market capitalization of USD 111.0 billion and volume of 12,009,345 shares.

CVS Health stock details

  • Company: CVS Health Corporation
  • ISIN: US1266501006
  • Ticker: CVS
  • Trading venue: NYSE
  • Price (as of October 5, 2026, 4:00 p.m. ET): USD 87.01
  • Market capitalization: USD 111.0 billion (as of October 5, 2026)
  • 52-week range: USD 69.51-110.68 (as of October 5, 2026)
  • Sector / Industry: Healthcare / Healthcare Plans
  • Index membership: S&P 500

Upcoming dates for CVS Health stock

  • October 22, 2026: Ex-dividend date
  • November 2, 2026: Quarterly dividend payment
  • November 4, 2026: Third-quarter 2026 results

More news and analyses on CVS Health stock

Disclaimer...

en | US1266501006 | CVS HEALTH CORP. | boerse | 70241712 | bgmi